Nicholas A. Kartsonis

Best Publications

• Comparison of caspofungin and amphotericin B for invasive candidiasis.

  Jorge Mora-Duarte;Robert Betts;Coleman Rotstein;Arnaldo Lopes Colombo

  1788
  Citations

• Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

  Francisco M Marty;Per Ljungman;Roy F Chemaly;Johan Maertens

  1187
  Citations

• Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

  Mark H. Wilcox;Dale N. Gerding;Ian R. Poxton;Ciaran Kelly

  875
  Citations

• Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

  Johan Maertens;Issam Raad;George Petrikkos;Marc Boogaerts

  805
  Citations

• RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections.

  Johann Motsch;Cláudia Murta de Oliveira;Viktor Stus;Iftihar Köksal

  429
  Citations

• Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.

  Vance G. Fowler;Keith B. Allen;Edson D. Moreira;Moustafa Moustafa

  404
  Citations

• A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis

  Alvaro Villanueva;Eduardo Gotuzzo;Eduardo G Arathoon;L.Miguel Noriega

  381
  Citations

• Antiretroviral resistance during successful therapy of HIV type 1 infection

  J. Martinez-Picado;M. P. DePasquale;N. Kartsonis;G. J. Hanna

  286
  Citations

• Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents

  Thomas J. Walsh;Peter C. Adamson;Nita L. Seibel;Patricia M. Flynn

  284
  Citations

• A Multicenter, Double-Blind Trial of a High-Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis

  Robert F. Betts;Marcio Nucci;Deepak Talwar;Marcelo Gareca

  261
  Citations

• Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis.

  Johan Maertens;Axel Glasmacher;Raoul Herbrecht;Anne Thiebaut

  259
  Citations

• A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).

  Ivan Titov;Richard G Wunderink;Antoine Roquilly;Daniel Rodríguez Gonzalez

  203
  Citations

• Caspofungin: the first in a new class of antifungal agents.

  Unknown

  193
  Citations

• Caspofungin Susceptibility Testing of Isolates from Patients with Esophageal Candidiasis or Invasive Candidiasis: Relationship of MIC to Treatment Outcome

  Unknown

  188
  Citations

• Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections.

  Unknown

  186
  Citations

• Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection

  Unknown

  184
  Citations

• Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

  Oliver A. Cornely;Rafael F. Duarte;Shariq Haider;Pranatharthi Chandrasekar

  182
  Citations

• A Randomized, Double-Blind, Multicenter Study of Caspofungin Versus Liposomal Amphotericin B for Empiric Antifungal Therapy in Pediatric Patients With Persistent Fever and Neutropenia

  Johan A. Maertens;Luis Madero;Anne F. Reilly;Thomas Lehrnbecher

  180
  Citations

• Caspofungin for the treatment of less common forms of invasive candidiasis

  Oliver A. Cornely;Martin Lasso;Robert Betts;Nickolay Klimko

  177
  Citations

• Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis.

  A. L. Colombo;J. Perfect;M. DiNubile;K. Bartizal

  171
  Citations